Lv1
40 积分 2024-03-25 加入
Emerging evidence for sequencing and combining PSMA-based therapies in prostate cancer
4天前
已完结
Blocking the neonatal Fc receptor as a novel approach to prevent cardiac neonatal lupus: a proof-of-concept study
5天前
已关闭
Repetitive nerve stimulation normalization after FcRn inhibitor therapy in refractory myasthenia gravis: A case report
5天前
已完结
Tumor-intrinsic regulators of the immune-cold microenvironment of prostate cancer
19天前
已完结
Genetic and phenotypic frequency distribution of CYP2C9, CYP2C19 and CYP2D6 in over 3200 Han Chinese
22天前
已完结
Assessing pharmacokinetic differences in Caucasian and East Asian (Japanese, Chinese and Korean) populations driven by CYP2C19 polymorphism using physiologically-based pharmacokinetic modelling
22天前
已完结
Myasthenia Gravis
6个月前
已完结
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
6个月前
已完结
The DNA damage response and cancer therapy
6个月前
已完结
皖公网安备34019202002308
